PODD
Insulet Corporation
Medical Devices · Healthcare · United States
152.50
close · 2026-10-29
value
37
cheaper than peers37
quality
94
stronger fundamentals94
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 19.75× | 56 |
| EV to EBITDA | 16.59× | 47 |
| price to sales | 3.24× | 46 |
| price to book | 7.44× | 23 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 26.0% | 95 |
| operating margin | 16.2% | 87 |
| revenue growth | 23.5% | 82 |
| debt to equity | 66.7% | 41 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $236.9M |
| employees | 5,400 |
| first trade | 2007-05-15 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 3.48 | 5.78 | 2.94 | 0.07 |
| free cash flow | $349.9M | $296.2M | $36.5M | -$38.3M |
| net income | $247.1M | $418.3M | $206.3M | $4.6M |
| revenue | $2.71B | $2.07B | $1.70B | $1.31B |
| unusual items | -$111.4M | $0 | $0 | $0 |